Search Results - "Dahmen, R."

Refine Results
  1. 1

    Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml by Steinstraesser, A., Schmidt, R., Bergmann, K., Dahmen, R., Becker, R. H. A.

    Published in Diabetes, obesity & metabolism (01-09-2014)
    “…Insulin glargine is processed in vivo into soluble 21A‐Gly‐human insulin (M1), the principal moiety responsible for metabolic effects, and subsequently into…”
    Get full text
    Journal Article
  2. 2

    Single-dose new insulin glargine 300U/ml provides prolonged, stable glycaemic control in Japanese and European people with type 1 diabetes by Shiramoto, M, Eto, T, Irie, S, Fukuzaki, A, Teichert, L, Tillner, J, Takahashi, Y, Koyama, M, Dahmen, R, Heise, T, Becker, R H A

    Published in Diabetes, obesity & metabolism (01-03-2015)
    “…Aims Two single-dose studies were conducted in Japan and Europe to compare the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of new insulin glargine…”
    Get full text
    Journal Article
  3. 3

    Single-dose new insulin glargine 300 U/ml provides prolonged, stable glycaemic control in Japanese and European people with type 1 diabetes by Shiramoto, M., Eto, T., Irie, S., Fukuzaki, A., Teichert, L., Tillner, J., Takahashi, Y., Koyama, M., Dahmen, R., Heise, T., Becker, R. H. A.

    Published in Diabetes, obesity & metabolism (01-03-2015)
    “…Aims Two single‐dose studies were conducted in Japan and Europe to compare the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of new insulin glargine…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Data-driven directions for effective footwear provision for the high-risk diabetic foot by Arts, M. L. J., de Haart, M., Waaijman, R., Dahmen, R., Berendsen, H., Nollet, F., Bus, S. A.

    Published in Diabetic medicine (01-06-2015)
    “…Aims Custom‐made footwear is used to offload the diabetic foot to prevent plantar foot ulcers. This prospective study evaluates the offloading effects of…”
    Get full text
    Journal Article
  6. 6

    Experiences with information provision and preferences for decision making of patients with acute stroke by Prick, J.C.M., Zonjee, V.J., van Schaik, S.M., Dahmen, R., Garvelink, M.M., Brouwers, P.J.A.M., Saxena, R., Keus, S.H.J., Deijle, I.A., van Uden-Kraan, C.F., van der Wees, P.J., Van den Berg-Vos, R.M.

    Published in Patient education and counseling (01-05-2022)
    “…The aim of this study was to gain insight into experiences of patients with acute stroke regarding information provision and their preferred involvement in…”
    Get full text
    Journal Article
  7. 7

    Higher body mass index is associated with lower foot health in patients with rheumatoid arthritis: baseline results of the Amsterdam-Foot cohort by Dahmen, R, Konings-Pijnappels, A, Kerkhof, S, Verberne, S, Boers, M, Roorda, LD, van der Leeden, M

    Published in Scandinavian journal of rheumatology (03-05-2020)
    “…Objective: Obesity is highly prevalent in patients with rheumatoid arthritis (RA), with likely impact on weight-bearing foot joints. We explored the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Forefoot pathology in relation to plantar pressure distribution in patients with rheumatoid arthritis: A cross-sectional study in the Amsterdam Foot cohort by Konings-Pijnappels, A.P.M., Tenten-Diepenmaat, M., Dahmen, R., Verberne, S.K., Dekker, J., Twisk, J.W.R., Roorda, L.D., van der Leeden, M.

    Published in Gait & posture (01-02-2019)
    “…•Forefoot pathology was assessed with clinically easy to obtain measures.•Plantar pressures were measured in the medial, central and lateral forefoot.•Regions…”
    Get full text
    Journal Article
  10. 10

    Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas by DAHMEN, R. P, KOCH, A, DENKHAUS, D, TONN, J. C, SÖRENSEN, N, BERTHOLD, F, BEHRENS, J, BIRCHMEIER, W, WIESTLER, O. D, PIETSCH, T

    Published in Cancer research (Chicago, Ill.) (01-10-2001)
    “…Medulloblastoma (MB) represents the most frequent malignant brain tumor in children. Most MBs appear sporadically; however, their incidence is highly elevated…”
    Get full text
    Journal Article
  11. 11

    Long-term follow-up of a randomized clinical trial comparing Beger with pylorus-preserving Whipple procedure for chronic pancreatitis by Müller, M. W., Friess, H., Martin, D. J., Hinz, U., Dahmen, R., Büchler, M. W.

    Published in British journal of surgery (01-03-2008)
    “…Background: Duodenum‐preserving pancreatic head resection according to Beger and the pylorus‐preserving Whipple (ppWhipple) procedure were compared in patients…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Morning administration of 0.4U/kg/day insulin glargine 300U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100U/mL in type 1 diabetes by Bailey, T.S., Pettus, J., Roussel, R., Schmider, W., Maroccia, M., Nassr, N., Klein, O., Bolli, G.B., Dahmen, R.

    Published in Diabetes & metabolism (01-02-2018)
    “…To compare steady state pharmacodynamic and pharmacokinetic profiles of insulin glargine 300U/mL (Gla-300) with insulin degludec 100U/mL (Deg-100) in people…”
    Get full text
    Journal Article
  14. 14

    A Population Dose–Response Model for Inhaled Technosphere Insulin Administered to Healthy Subjects by Rüppel, D, Dahmen, R, Boss, A, Jäger, R, Grant, M, Baughman, R, Klabunde, T

    “…Technosphere insulin (TI), an inhaled insulin with a fast onset of action, provides a novel option for the control of prandial glucose. A euglycemic glucose…”
    Get full text
    Journal Article
  15. 15

    Counting integral Lamé equations by means of dessins d'enfants by Dahmen, Sander R.

    “…We obtain an explicit formula for the number of Lamé equations (modulo linear changes of variable) with index n and projective monodromy group of order 2N, for…”
    Get full text
    Journal Article
  16. 16

    Employment-Related Concerns of HIV-Positive People in the Netherlands: Input for a Multidisciplinary Guideline by Wagener, M. N., van Opstal, S. E. M., Miedema, H. S., Brandjes, D. P. M., Dahmen, R., van Gorp, E. C. M., Roelofs, P. D. D. M.

    Published in Journal of occupational rehabilitation (01-12-2014)
    “…Purpose Finding and keeping employment is difficult for people with HIV. To improve supportive care for people with HIV and employment-related problems, a…”
    Get full text
    Journal Article
  17. 17

    Postoperative long-term results in high-grade traumatic ruptures of the spleen in children by Weinrich, M, Dahmen, R P, Black, K J L, Lange, S A, Bindewald, H

    Published in Zentralblatt fur Chirurgie (01-12-2014)
    “…Splenic rupture is the most common injury in blunt abdominal trauma at any age. The grade of rupture, haemodynamic stability and, in the case of operative…”
    Get more information
    Journal Article
  18. 18

    P306 Le métabolisme de l’insuline glargine in vivo chez l’homme est le même après administration de l’insuline glargine 100 (Gla-100) et de l’insuline glargine 300 (Gla-300) by Monnier, L, Bergmann, K, Dahmen, R, Becker, R, Schmidt, R

    Published in Diabetes & metabolism (01-03-2014)
    “…Objectif La nouvelle insuline glargine U300 (Gla-300, 300 U/ml) possède un profil pharmacocinétique et pharmacodynamique amélioré par rapport à Gla-100 (100…”
    Get full text
    Journal Article
  19. 19

    A Formalization of Dedekind Domains and Class Groups of Global Fields by Baanen, Anne, Dahmen, Sander R., Narayanan, Ashvni, Nuccio Mortarino Majno di Capriglio, Filippo A. E.

    Published in Journal of automated reasoning (01-11-2022)
    “…Dedekind domains and their class groups are notions in commutative algebra that are essential in algebraic number theory. We formalized these structures and…”
    Get full text
    Journal Article
  20. 20

    P307 La nouvelle insuline glargine U300 (Gla-300, 300 U/ml) présente à l’état d’équilibre un profil avec une durée d’action plus prolongée et stable by Halimi, S, Jax, T, Dahmen, R, Bergmann, K, Lehmann, A, Tillner, J, Becker, R, Heise, T

    Published in Diabetes & metabolism (01-03-2014)
    “…Objectif La nouvelle insuline glargine U300 (Gla-300, 300 U/ml) en doses uniques sous-cutanée possède une durée d’action plus prolongée et un profil…”
    Get full text
    Journal Article